JNJ-38877618

· Janssen Cilag N.V./S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-38877618, covering 2014-09-12 to 2014-09-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male Participants [Phase 1]

See pricing